Logo image of 1CLNX.MI

CELLNEX TELECOM SA (1CLNX.MI) Stock Fundamental Analysis

BIT:1CLNX - Euronext Milan - ES0105066007 - Common Stock - Currency: EUR

33.24  +2.87 (+9.45%)

Fundamental Rating

2

1CLNX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 32 industry peers in the Diversified Telecommunication Services industry. 1CLNX has a bad profitability rating. Also its financial health evaluation is rather negative. 1CLNX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1CLNX was profitable.
1CLNX had a positive operating cash flow in the past year.
1CLNX had negative earnings in each of the past 5 years.
Each year in the past 5 years 1CLNX had a positive operating cash flow.
1CLNX.MI Yearly Net Income VS EBIT VS OCF VS FCF1CLNX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

1CLNX's Return On Assets of -0.06% is on the low side compared to the rest of the industry. 1CLNX is outperformed by 71.88% of its industry peers.
Looking at the Return On Equity, with a value of -0.20%, 1CLNX is doing worse than 71.88% of the companies in the same industry.
The Return On Invested Capital of 1CLNX (1.69%) is worse than 84.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1CLNX is significantly below the industry average of 7.75%.
The last Return On Invested Capital (1.69%) for 1CLNX is above the 3 year average (0.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.06%
ROE -0.2%
ROIC 1.69%
ROA(3y)-0.47%
ROA(5y)-0.57%
ROE(3y)-1.47%
ROE(5y)-1.73%
ROIC(3y)0.76%
ROIC(5y)0.62%
1CLNX.MI Yearly ROA, ROE, ROIC1CLNX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

1CLNX has a better Operating Margin (20.59%) than 71.88% of its industry peers.
In the last couple of years the Operating Margin of 1CLNX has remained more or less at the same level.
The Profit Margin and Gross Margin are not available for 1CLNX so they could not be analyzed.
Industry RankSector Rank
OM 20.59%
PM (TTM) N/A
GM N/A
OM growth 3Y30.87%
OM growth 5Y-0.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1CLNX.MI Yearly Profit, Operating, Gross Margins1CLNX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CLNX is destroying value.
The number of shares outstanding for 1CLNX remains at a similar level compared to 1 year ago.
The number of shares outstanding for 1CLNX has been increased compared to 5 years ago.
1CLNX has a worse debt/assets ratio than last year.
1CLNX.MI Yearly Shares Outstanding1CLNX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1CLNX.MI Yearly Total Debt VS Total Assets1CLNX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

1CLNX has an Altman-Z score of 0.54. This is a bad value and indicates that 1CLNX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 1CLNX (0.54) is worse than 87.50% of its industry peers.
1CLNX has a debt to FCF ratio of 77.61. This is a negative value and a sign of low solvency as 1CLNX would need 77.61 years to pay back of all of its debts.
The Debt to FCF ratio of 1CLNX (77.61) is worse than 78.13% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that 1CLNX has dependencies on debt financing.
1CLNX has a worse Debt to Equity ratio (1.38) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 77.61
Altman-Z 0.54
ROIC/WACC0.31
WACC5.36%
1CLNX.MI Yearly LT Debt VS Equity VS FCF1CLNX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.59 indicates that 1CLNX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.59, 1CLNX is doing worse than 81.25% of the companies in the same industry.
A Quick Ratio of 0.59 indicates that 1CLNX may have some problems paying its short term obligations.
1CLNX has a Quick ratio of 0.59. This is in the lower half of the industry: 1CLNX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
1CLNX.MI Yearly Current Assets VS Current Liabilites1CLNX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 296.16% over the past year.
The Revenue has been growing slightly by 7.55% in the past year.
1CLNX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.20% yearly.
EPS 1Y (TTM)296.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%907.14%
Revenue 1Y (TTM)7.55%
Revenue growth 3Y19.79%
Revenue growth 5Y34.2%
Sales Q2Q%10.54%

3.2 Future

1CLNX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.79% yearly.
The Revenue is expected to grow by 3.99% on average over the next years.
EPS Next Y-103.76%
EPS Next 2Y-46.99%
EPS Next 3Y-22.79%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y4.86%
Revenue Next 3Y4.29%
Revenue Next 5Y3.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CLNX.MI Yearly Revenue VS Estimates1CLNX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
1CLNX.MI Yearly EPS VS Estimates1CLNX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

0

4. Valuation

4.1 Price/Earnings Ratio

1CLNX is valuated quite expensively with a Price/Earnings ratio of 40.54.
1CLNX's Price/Earnings ratio is a bit more expensive when compared to the industry. 1CLNX is more expensive than 75.00% of the companies in the same industry.
1CLNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.17.
1CLNX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 40.54
Fwd PE N/A
1CLNX.MI Price Earnings VS Forward Price Earnings1CLNX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1CLNX indicates a slightly more expensive valuation: 1CLNX is more expensive than 78.13% of the companies listed in the same industry.
78.13% of the companies in the same industry are cheaper than 1CLNX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 85.01
EV/EBITDA 12.51
1CLNX.MI Per share data1CLNX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A cheap valuation may be justified as 1CLNX's earnings are expected to decrease with -22.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.99%
EPS Next 3Y-22.79%

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.18%, 1CLNX is not a good candidate for dividend investing.
1CLNX's Dividend Yield is slightly below the industry average, which is at 4.30.
With a Dividend Yield of 0.18, 1CLNX pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1CLNX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-158.39%
EPS Next 2Y-46.99%
EPS Next 3Y-22.79%
1CLNX.MI Yearly Income VS Free CF VS Dividend1CLNX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CELLNEX TELECOM SA

BIT:1CLNX (5/20/2025, 7:00:00 PM)

33.24

+2.87 (+9.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-07 2025-05-07
Inst Owners67.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.48B
Analysts79.43
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-158.39%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2915.95%
Min EPS beat(2)1321.84%
Max EPS beat(2)4510.07%
EPS beat(4)3
Avg EPS beat(4)1338.26%
Min EPS beat(4)-496.55%
Max EPS beat(4)4510.07%
EPS beat(8)5
Avg EPS beat(8)666.12%
EPS beat(12)6
Avg EPS beat(12)441.69%
EPS beat(16)7
Avg EPS beat(16)275.31%
Revenue beat(2)2
Avg Revenue beat(2)5.06%
Min Revenue beat(2)3.93%
Max Revenue beat(2)6.18%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.19%
Max Revenue beat(4)6.18%
Revenue beat(8)6
Avg Revenue beat(8)6.22%
Revenue beat(12)7
Avg Revenue beat(12)4.3%
Revenue beat(16)7
Avg Revenue beat(16)2.63%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 40.54
Fwd PE N/A
P/S 5.39
P/FCF 85.01
P/OCF 10.18
P/B 1.66
P/tB N/A
EV/EBITDA 12.51
EPS(TTM)0.82
EY2.47%
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.39
FCFY1.18%
OCF(TTM)3.26
OCFY9.82%
SpS6.16
BVpS20.04
TBVpS-12.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.2%
ROCE 2.25%
ROIC 1.69%
ROICexc 1.73%
ROICexgc 4.24%
OM 20.59%
PM (TTM) N/A
GM N/A
FCFM 6.34%
ROA(3y)-0.47%
ROA(5y)-0.57%
ROE(3y)-1.47%
ROE(5y)-1.73%
ROIC(3y)0.76%
ROIC(5y)0.62%
ROICexc(3y)0.78%
ROICexc(5y)0.67%
ROICexgc(3y)2.03%
ROICexgc(5y)1.83%
ROCE(3y)1.01%
ROCE(5y)0.83%
ROICexcg growth 3Y37.67%
ROICexcg growth 5Y1.89%
ROICexc growth 3Y51.7%
ROICexc growth 5Y1.69%
OM growth 3Y30.87%
OM growth 5Y-0.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 77.61
Debt/EBITDA 5.57
Cap/Depr 77.84%
Cap/Sales 46.62%
Interest Coverage 1.2
Cash Conversion 65.81%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 0.54
F-Score6
WACC5.36%
ROIC/WACC0.31
Cap/Depr(3y)90.17%
Cap/Depr(5y)87.73%
Cap/Sales(3y)58.1%
Cap/Sales(5y)56.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)296.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%907.14%
EPS Next Y-103.76%
EPS Next 2Y-46.99%
EPS Next 3Y-22.79%
EPS Next 5YN/A
Revenue 1Y (TTM)7.55%
Revenue growth 3Y19.79%
Revenue growth 5Y34.2%
Sales Q2Q%10.54%
Revenue Next Year4.74%
Revenue Next 2Y4.86%
Revenue Next 3Y4.29%
Revenue Next 5Y3.99%
EBIT growth 1Y139.71%
EBIT growth 3Y56.77%
EBIT growth 5Y33.28%
EBIT Next Year830.59%
EBIT Next 3Y118.73%
EBIT Next 5Y60.8%
FCF growth 1Y319.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.55%
OCF growth 3Y26.44%
OCF growth 5Y40.62%